Abstract: The present invention provides a system for managing occlusions during phacoemulsification surgery. More specifically, the present invention provides a user of a surgical console an alert when a partial or full occlusion of a surgical tool causes the vacuum pressure to become greater than a predetermined pressure threshold setting and automatically reduces the vacuum pressure when the predetermined pressure threshold setting is exceeded.
Type:
Grant
Filed:
October 4, 2017
Date of Patent:
April 30, 2024
Assignee:
Johnson & Johnson Surgical Vision, Inc.
Inventors:
Abraham Hajishah, Edith W. Fung, Deep Mehta
Abstract: Disclosed herein are compositions and methods comprising a composition for light filtering. An example composition comprises a plurality of metal nanoparticles, at least a portion of the plurality of metal nanoparticles having an anisotropic shape; and a stabilizing mechanism disposed to selectively couple with at least a portion of the plurality of metal nanoparticles, wherein the composition exhibits a peak light filtering value in the range of about 600 nm to about 850 nm.
Type:
Grant
Filed:
April 28, 2022
Date of Patent:
April 30, 2024
Assignee:
Johnson & Johnson Vision Care, Inc.
Inventors:
Frank Gu, Aaron Joshua Clasky, Paul Chen
Abstract: The present invention relates to compositions comprising one or more extracts and/or compounds having retinol-like activity and properties and methods of using the compositions to treat the eye.
Abstract: The present invention relates to compositions comprising one or more compounds and/or extracts which induce, promote and/or improve production/release/delivery/excretion of hyaluronic acid and/or mucin from and/or in the cornea, and methods of using the compositions to treat the eye.
Abstract: A system includes a needle, an actuator assembly and a generator. The needle is configured to be vibrated so as to emulsify a lens of an eye. The actuator assembly, includes a first actuator, a second actuator and a third actuator, which are distributed around a longitudinal axis of the needle and are configured to vibrate along the longitudinal axis in response to a first driving signal, a second driving signal and a third driving signal, respectively. The generator is configured to generate the first driving signal, the second driving signal and the third driving signal, so as to vibrate the needle in accordance with a predefined pattern.
Abstract: Described are polymerizable high energy light absorbing compounds of formula I: Wherein Y, Pg, R2, R3, R4, R5, and R6 are as described herein. The compounds absorb various wavelengths of ultraviolet and/or high energy visible light and are suitable for incorporation in various products, such as biomedical devices and ophthalmic devices.
Type:
Grant
Filed:
May 27, 2021
Date of Patent:
April 30, 2024
Assignee:
Johnson & Johnson Vision Care, Inc.
Inventors:
Ghulam Maharvi, Shivkumar Mahadevan, Stephen C. Arnold, Patricia Martin, Leilani K. Sonoda, Dola Sinha
Abstract: Disclosed are co-polymers which are produced from reactive monomer mixtures and which have both high refractive index and a high Abbe number. These materials are well suited for use as implantable ophthalmic devices and have a refractive index which may be edited through application of energy. When used for an intraocular lens, the high refractive index allows for a thin lens which compresses to allow a small incision size.
Type:
Grant
Filed:
March 24, 2023
Date of Patent:
April 16, 2024
Assignee:
Johnson & Johnson Surgical Vision, Inc.
Inventors:
Azaam Alli, Bart Johnson, Scott L. Joslin, Ghulam Maharvi
Abstract: A system for learning actual phacoemulsification energy setpoints at the time of occlusion breaks during ophthalmic surgery. Phacoemulsification energy setpoints may be recorded over different periods of time, such as during current cases and over a lifetime of cases. The recorded data would then be used to determine future phacoemulsification energy setting amounts.
Abstract: Described are visible light absorbing compounds. The compounds have a visible light absorption maximum between 430 and 480 nm and a full width half maximum (FWHM) at the visible light absorption maximum of at least 35 nm and up to 100 nanometers, wherein the compounds are photostable. The compounds substantially mimic the visible light absorbance properties of macular pigment while remaining photostable. The compounds may be used in a variety of articles, including ophthalmic devices.
Abstract: The present invention relates to copolymers, particularly to copolymers comprising a photoactive unit, the copolymers being particularly suitable for ophthalmic devices. The copolymers include one or more different polymer units in addition to the photoactive unit, such as polymerized units derived from ethylene, propylene, an acrylate, a methacrylate, or a styrene.
Type:
Grant
Filed:
July 30, 2021
Date of Patent:
April 16, 2024
Assignee:
Johnson & Johnson Surgical Vision, Inc.
Inventors:
Lars Dobelmann-Mara, Stefan Riedmueller, Martin Schraub
Abstract: A press for shaping an absorbent tampon blank into a shaped tampon pledget includes a central cavity arranged and configured to accommodate an absorbent tampon blank having a front portion and a back portion. The main longitudinal axis of the press passes in the middle of the central cavity and a plurality of penetrating dies are arranged radially around the said main longitudinal axis. Each penetrating die has a pressing face on at least a fragment of its side facing the central cavity. The said press comprises at least one cam to actuate the plurality of penetrating dies. Furthermore, the plurality of penetrating dies comprises at least one penetrating die having a pressing face with a first shaped longitudinal profile, and least one penetrating die having a pressing face with a second shaped longitudinal profile.
Type:
Grant
Filed:
September 16, 2020
Date of Patent:
April 9, 2024
Assignee:
Johnson & Johnson GmbH
Inventors:
Nick Brooks, David L. Kimball, Peter Morgan, James Stembridge
Abstract: This invention relates to comfortable ophthalmic devices and methods of producing such devices.
Type:
Grant
Filed:
August 24, 2021
Date of Patent:
April 9, 2024
Assignee:
Johnson & Johnson Vision Care, Inc.
Inventors:
Kevin P. McCabe, Robert B. Steffen, Hélène Aguilar, W. Anthony Martin, Susan W. Neadle, Ann-Marie Wong Meyers, Douglas G. Vanderlaan, Dominic P. Gourd, Kristy L. Canavan, Gregory A. Hill
Abstract: An apparatus, system and method for a phacoemulsification handpiece. The phacoemulsification handpiece may include: a proximal portion having a longitudinal axis, and a first end and a second end, wherein at least aspiration, irrigation and power connectors couple with the first end; a distal portion along the longitudinal axis and comprising a coupling configured to couple a needle with the distal portion; and a lever connectively associated with the coupling extending outwardly from the coupling through the distal portion, wherein actuation of the outwardly extending aspect of the lever provides a rotation of the coupling independent of rotation of the distal portion.
Abstract: A storage container for contact lenses has a well for receiving a contact lens and a storage liquid and a floor. A support structure of the storage container holds the contact lens in a defined location above the floor of the well, the defined location having a lens depression area that in use permits depression of the contact lens under finger pressure, where the support structure supports a concave surface of a contact lens and acts as a fulcrum wherein the contact lens pivots about the fulcrum such a contact surface area of the contact lens deforms when pressure is applied to a portion of the contact lens in the depression area.
Type:
Grant
Filed:
May 12, 2021
Date of Patent:
April 2, 2024
Assignee:
Johnson & Johnson Vision Care, Inc.
Inventors:
Anthony John Greenwood, Guy St John Tristram Smith
Abstract: The present invention relates to a method of manufacturing a contact lens including the steps of: (i) adding reactive components to a mold, wherein the reactive components comprise (a) at least one hydroxy-containing silicone component having a weight average molecular weight from about 200 to about 15,000 g/mole and (b) at least one mono-ether terminated, mono-methacrylate terminated polyethylene glycol having a weight average molecular weight from about 200 to about 10,000 g/mole; (ii) curing the reactive components within the mold to form the contact lens; and (iii) removing the contact lens from said mold.